XGN XGN
Company Profile ↓Company Overview
XGN (XGN) is a publicly traded company listed on with a market capitalization of $103.79M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Net profit has compounded at 19.3% per year over the last five years.
Revenue has grown at a 13.5% CAGR over the past five years.
Recent Developments
- Dec 2025 Revenue of $66.58M (+19.7% YoY); net profit $-19.95M.
- Trailing 12 Months Year-on-year growth — revenue +19.7%.
- 5-Year Trend Long-term compounding — revenue CAGR 13.5%, profit CAGR 19.3%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 13.47% |
| 1 Year: | 19.65% |
Compounded Profit Growth
| 5 Years: | 19.30% |
| 1 Year: | - |
Stock Price Performance
| 1 Year: | -47.51% |
| 6 Months: | +14.68% |
| 3 Months: | +56.21% |
| 1 Month: | -3.82% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)50.39 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 13.5% over 5 years.
- Profit CAGR of 19.3% over 5 years.
CONS
- Trading 62.1% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 15.50M | 17.20M | 17.24M | 16.63M | 17.31M |
| Cost of Revenue | 6.38M | 6.81M | 7.17M | 7.42M | 7.10M |
| Gross Profit | 9.12M | 10.39M | 10.07M | 9.21M | 10.21M |
| Operating Expenses | 12.49M | 13.03M | 13.18M | 14.18M | 13.62M |
| Operating Income | -3.37M | -2.63M | -3.10M | -4.97M | -3.41M |
| EBITDA | -2.77M | -2.81M | -5.16M | -2.73M | -2.06M |
| Interest Expense | 545.00K | 1.12M | 1.32M | 1.33M | 1.27M |
| Pretax Income | -3.75M | -4.40M | -7.09M | -4.66M | -3.93M |
| Tax Provision | 0 | 37.00K | 1.00K | 13.00K | 36.00K |
| Net Income | -3.75M | -4.44M | -7.09M | -4.67M | -3.97M |
| Diluted EPS | -0.20 | -0.21 | -0.31 | -0.20 | -0.17 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 45.56M | 52.55M | 55.64M | 66.58M |
| Cost of Revenue | - | 24.21M | 23.09M | 22.53M | 27.78M |
| Gross Profit | - | 21.35M | 29.46M | 33.11M | 38.80M |
| Operating Expenses | - | 61.89M | 52.29M | 46.75M | 52.87M |
| Operating Income | - | -40.55M | -22.84M | -13.64M | -14.07M |
| EBITDA | - | -43.66M | -19.15M | -11.14M | -13.46M |
| Interest Expense | - | 2.45M | 2.33M | 2.23M | 4.32M |
| Pretax Income | - | -47.67M | -23.66M | -15.10M | -19.90M |
| Tax Provision | - | -282.00K | 33.00K | 12.00K | 51.00K |
| Net Income | - | -47.39M | -23.69M | -15.12M | -19.95M |
| Diluted EPS | - | -2.77 | -1.34 | -0.83 | -0.93 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 86.22M | 56.94M | 44.69M | 58.02M |
| Current Assets | - | 72.61M | 47.84M | 36.45M | 48.89M |
| Cash & Equivalents | - | 62.39M | 36.49M | 22.04M | 32.22M |
| Inventory | - | - | - | - | - |
| Receivables | - | 6.08M | 6.55M | 7.83M | 10.86M |
| Total Liabilities | - | 43.76M | 34.25M | 35.15M | 40.57M |
| Current Liabilities | - | 9.62M | 11.90M | 13.51M | 14.16M |
| Long Term Debt | - | 28.78M | 19.23M | 19.82M | 22.26M |
| Total Debt | - | 35.20M | 23.23M | 23.21M | 25.71M |
| Total Equity | - | 42.46M | 22.69M | 9.54M | 17.45M |
| Shares Outstanding | - | 16.55M | 17.05M | 17.64M | 22.91M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -32.14M | -14.46M | -13.28M | -13.62M |
| Investing Cash Flow | - | -4.32M | -804.00K | -515.00K | -626.00K |
| Financing Cash Flow | - | -489.00K | -10.63M | -663.00K | 24.43M |
| Capital Expenditure | - | -4.32M | -828.00K | -515.00K | -641.00K |
| Free Cash Flow | - | -36.46M | -15.29M | -13.79M | -14.27M |
| Net Change in Cash | - | -36.95M | -25.90M | -14.46M | 10.18M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 46.9% | 56.1% | 59.5% | 58.3% |
| Operating Margin % | - | -89.0% | -43.5% | -24.5% | -21.1% |
| Net Margin % | - | -104.0% | -45.1% | -27.2% | -30.0% |
| ROE % | - | -111.6% | -104.4% | -158.4% | -114.3% |
| ROCE % | - | -52.9% | -50.7% | -43.7% | -32.1% |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for XGN
XGN — Frequently Asked Questions
What is the current share price of XGN?
As of 2026-08-02 19:16 PDT, XGN trades at $4.53 on NASDAQ/NYSE. Its 52-week range is $2.65 to $11.96.
What is the market capitalisation of XGN?
XGN has a market capitalisation of $103.79M on NASDAQ/NYSE.
What is the P/E ratio of XGN?
XGN trades at a trailing price-to-earnings (P/E) ratio of -4.87. Its price-to-book (P/B) ratio is 5.95.
What is the return on equity (ROE) of XGN?
XGN has a return on equity (ROE) of -114.34%. Its return on capital employed (ROCE) is -35.52%.
Is XGN a good stock to buy?
This page provides a data-driven analysis of XGN, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.